Johnson & Johnson (JNJ) DIvidends Date & History

Key Takeaways

• Johnson & Johnson (JNJ) offers a current dividend yield of approximately 2.02% with an annual payout of $5.36 per share.
• The company pays dividends quarterly and has increased its dividend for 64 consecutive years.
• Payout ratio stands near 60%, supported by strong free cash flow exceeding $20 billion annually.
• Dividend sustainability appears solid given earnings coverage and conservative balance sheet.
• Johnson & Johnson (JNJ) yield exceeds the healthcare sector average of about 1.63%.
• Attractive for long-term income and dividend growth investors seeking stability.

Dividend Overview

Johnson & Johnson (JNJ) maintains a consistent dividend policy focused on quarterly payments. The current annual dividend totals $5.36 per share, translating to a yield of roughly 2.02% based on recent share prices near $265.58. Payments occur every three months, with the most recent ex-dividend date on August 25, 2026, and payment on September 8, 2026. The company qualifies as a dividend growth stock rather than a high-yield name, emphasizing steady increases over decades alongside its diversified healthcare operations in pharmaceuticals and medical devices.

Dividend History and Growth

Johnson & Johnson (JNJ) has raised its dividend annually for 64 consecutive years, earning Dividend King status. Recent increases include a lift to $1.34 per share quarterly in 2026 from $1.30 previously. Over the past five years, dividend growth has averaged near 5% annually. The firm has never cut dividends and demonstrates a long-term strategy of modest, sustainable raises tied to earnings growth and cash generation.

Dividend Sustainability and Payout Ratio

The payout ratio hovers around 60%, indicating moderate earnings coverage while leaving room for reinvestment. Free cash flow of approximately $20 billion annually provides ample support, covering dividends multiple times over. Debt levels remain manageable with a debt-to-equity ratio near 58%, and the company holds an investment-grade credit profile. These factors point to strong dividend sustainability even amid patent expirations and industry shifts.

Dividend Compared to Industry Peers

Johnson & Johnson (JNJ) dividend yield of about 2.02% exceeds the healthcare sector average of roughly 1.63%. Peers such as Pfizer and Merck often show higher yields but with elevated payout ratios exceeding 200% in some cases. In contrast, JNJ balances a moderate yield with superior consistency and lower payout stress, positioning it favorably among large-cap healthcare dividend payers for reliability.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Investors seeking dividend opportunities may explore the tool for tailored insights.

Is This Stock Attractive for Dividend Investors?

Johnson & Johnson (JNJ) appeals primarily to conservative, long-term dividend growth investors who prioritize reliability over high current yields. Its Dividend King track record, diversified revenue streams, and robust cash flow generation support ongoing increases without excessive risk. Income-focused investors may value the quarterly cadence and sector stability, while those seeking higher yields might consider peers with greater payout ratios. The stock suits portfolios emphasizing capital preservation and gradual income growth in the healthcare space, though investors should monitor industry dynamics such as drug competition and regulatory factors. No investment advice is provided.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations